BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24793015)

  • 21. Association between ERCC1 and XPF polymorphisms and risk of colorectal cancer.
    Yang H; Li G; Li WF
    Genet Mol Res; 2015 Jan; 14(1):700-5. PubMed ID: 25730007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic variability of DNA repair mechanisms in chemotherapy treatment outcome of gastric cancer patients.
    Zhong G; Li HK; Shan T; Zhang N
    Genet Mol Res; 2015 Dec; 14(4):17228-34. PubMed ID: 26681216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of common ERCC1 polymorphisms in cisplatin-resistant epithelial ovarian cancer patients: A study in Chinese cohort.
    Bao Y; Yang B; Zhao J; Shen S; Gao J
    Int J Immunogenet; 2020 Oct; 47(5):443-453. PubMed ID: 32173978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A nonsense mutation in the Xeroderma pigmentosum complementation group F (XPF) gene is associated with gastric carcinogenesis.
    Wei ZH; Guo WH; Wu J; Suo WH; Fu GH
    Gene; 2014 Mar; 537(2):238-44. PubMed ID: 24412486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ERCC1 and ERCC2 variants predict survival in gastric cancer patients.
    Li Y; Liu Z; Liu H; Wang LE; Tan D; Ajani JA; Wei QY
    PLoS One; 2013; 8(9):e71994. PubMed ID: 24023723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic variability of ERCC1 and ERCC2 genes involved in the nucleotide excision repair pathway influences the treatment outcome of gastric cancer.
    Zheng DL; Tang GD; Chen YN; Zhang T; Qin MB
    Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influences of ERCC1, ERCC2, XRCC1, GSTP1, GSTT1, and MTHFR polymorphisms on clinical outcomes in gastric cancer patients treated with EOF chemotherapy.
    Liu R; Zhao X; Liu X; Chen Z; Qiu L; Geng R; Guo W; He G; Yin J; Li J; Zhu X
    Tumour Biol; 2016 Feb; 37(2):1753-62. PubMed ID: 26314858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between ERCC1 and ERCC2 gene polymorphisms and chemotherapy response and overall survival in osteosarcoma.
    Cao ZH; Yin HP; Jiang N; Yu B
    Genet Mol Res; 2015 Aug; 14(3):10145-51. PubMed ID: 26345951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of genetic polymorphisms in ERCC1 and ERCC2/XPD with risk of chronic benzene poisoning in a Chinese occupational population.
    Xiao S; Gao L; Liu Y; Yu T; Jin C; Pan L; Zhu G; Lu X
    Mutat Res; 2013 Feb; 751(1):52-8. PubMed ID: 23147699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of NER pathway gene polymorphisms with susceptibility to laryngeal cancer in a Chinese population.
    Sun Y; Tan L; Li H; Qin X; Liu J
    Int J Clin Exp Pathol; 2015; 8(9):11615-21. PubMed ID: 26617899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Polymorphisms of ERCC1 gene and outcomes in epithelial ovarian cancer patients with platinum-based chemotherapy].
    Qi BL; Li Y; Wang N; Zhou RM; Hu P; Kang S
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):847-52. PubMed ID: 24444563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphisms in ERCC1 gene could predict clinical outcome of platinum-based chemotherapy for non-small cell lung cancer patients.
    Zhao X; Zhang Z; Yuan Y; Yuan X
    Tumour Biol; 2014 Aug; 35(8):8335-41. PubMed ID: 24859833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of excision repair cross complementation group 1 rs2298881 in patients with gastric cancer receiving platinum-based chemotherapy: A PRISMA-compliant meta-analysis.
    Lv Y; Xu M; Sun Y; Liu Y; Zhao L; Liu X; Li Z; Shi G; Jia J; Bi L; Ma N; Zhang X; Qi C
    Medicine (Baltimore); 2021 Aug; 100(33):e26850. PubMed ID: 34414935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A genetic variant in ERCC2 is associated with gastric cancer prognosis in a Chinese population.
    Chu H; Gu D; Xu M; Xu Z; Gong Y; Gong W; Tang Y; Zhou J; Tong N; Zhang Z; Chen J; Wang M
    Mutagenesis; 2013 Jul; 28(4):441-6. PubMed ID: 23680703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between ERCC1 and ERCC2 gene polymorphisms and susceptibility to pancreatic cancer.
    He MG; Zheng K; Tan D; Wang ZX
    Genet Mol Res; 2016 Mar; 15(1):. PubMed ID: 27051038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic variation in ERCC1 and XPF genes and breast cancer risk.
    Pei XH; Yang Z; Lv XQ; Li HX
    Genet Mol Res; 2014 Mar; 13(1):2259-67. PubMed ID: 24737474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of single nucleotide polymorphisms of DNA repair genes in NER pathway and susceptibility to pancreatic cancer.
    Zhao F; Shang Y; Zeng C; Gao D; Li K
    Int J Clin Exp Pathol; 2015; 8(9):11579-86. PubMed ID: 26617894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of single nucleotide polymorphisms of DNA repair genes in susceptibility to pancreatic cancer in Chinese population.
    Ying MF; Zhao R
    Genet Mol Res; 2016 Mar; 15(1):. PubMed ID: 27050953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Associations of polymorphisms in DNA repair genes and MDR1 gene with chemotherapy response and survival of non-small cell lung cancer.
    Du Y; Su T; Zhao L; Tan X; Chang W; Zhang H; Cao G
    PLoS One; 2014; 9(6):e99843. PubMed ID: 24933103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation on the DNA repaired gene polymorphisms and response to chemotherapy and overall survival of osteosarcoma.
    Ji WP; He NB
    Int J Clin Exp Pathol; 2015; 8(1):894-9. PubMed ID: 25755792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.